Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atrium Health Levine Cancer Institute (LCI) is a leading cancer research and treatment center based in Charlotte, North Carolina, and is part of the Advocate Health system. The institute operates a vast network of more than 25 locations across the Carolinas, providing comprehensive oncology services including advanced radiation therapy, surgical oncology, and a nationally recognized bone marrow transplant program. LCI is distinguished by its robust Phase I Clinical Trials Unit, which offers patients early access to innovative experimental therapeutics and precision medicine. By integrating academic-level research with a community-based care model, the institute focuses on delivering high-quality cancer treatment close to patients' homes. LCI is also a major site for cellular therapy development, including CAR-T cell treatments and other advanced immunotherapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atrium Health Levine Cancer Institute.